in this issue

issue 20 // october 2019

in this issue

issue 20 // october 2019

Diabetes is a relatively common and easily managed condition, but for many patients monitoring insulin intake remains an arduous and irritating task. So what is being done to help make this easier for patients? We take a look at ways that technology is being used to make improve diabetes care. Plus, we speak to industry insiders to uncover the most important factors to think about when choosing a contract manufacturer.


Also, we take a look at the legitimacy of femtech innovations and the companies looking to tap into the lucrative field of fertility treatments, debate the benefits and challenges of using Amazon’s Alexa voice assistant to bring NHS-certified medical information to patients in their own homes, and examine the potential of HeartFlow Analysis, which uses data from CAT scans to generated a 3D model of a patient’s heart.


Plus, we find out how innovations in neurotechnology-based therapies are benefitting patients, delve into the virtual world of prescription video games with the team behind Akili Interactive’s immersive product that is said to help to treat and manage ADHD, and get the inside scoop on med tech investment funds with life sciences venture capital fund Vesalius Biocapital.


Eloise McLennan, editor

Go to article: Home | Hey Alexa: what are the symptoms of...?Go to article: In This Issue Go to article: MPS Microsystems Company InsightGo to article: MPS MicrosystemsGo to article: ContentsGo to article: Sandvik Company InsightGo to article: Sandvik Go to article: NewsGo to article: MicronovaGo to article: The Medical Industry BriefingGo to article: Formacoat Company InsightGo to article: FormacoatGo to article: Future diabetes care: deep brain stimulation and implanted insulinGo to article: Siemens Company Insight Go to article: Siemens Go to article: Roundtable: choosing a contract device manufacturerGo to article: Telemed Company InsightGo to article: TelemedGo to article: Debate: Can Alexa be trusted with our health questions?Go to article: MikronGo to article: HeartFlow Analysis: a better way to diagnose heart disease? Go to article: Tricor SystemsGo to article: The Promise of Neurotechnology Go to article: Laser Wire Solutions Company InsightGo to article: Laser Wire SolutionsGo to article: Cashing in on fertility: should femtech receive more scrutiny?Go to article: Accurate Biometrics Company InsightGo to article: Accurate BiometricsGo to article: Q&A: Ready player one: booting up the prescription video gameGo to article: SartoriusGo to article: Omnitron Go to article: Q&A: an inside look at medtech venture capital with VesaliusGo to article: AerogelexGo to article: CarmoGo to article: Electronic ‘nose’ can predict response to lung cancer immunotherapyGo to article: TreskyGo to article: Smiths InterconnectGo to article: AI demonstrates human-level capacity to diagnose diseaseGo to article: Maraca InternationalGo to article: Axonics Modulation Technologies emerges as a major player in sacral neuromodulationGo to article: OptelGo to article: CMR Surgical joins surgical robots battle with next generation VersiusGo to article: Art of TechnologyGo to article: First long-distance PCI procedure in India opens an opportunity for untapped patient poolGo to article: EventsGo to article: Next Issue